Evidence map›Paper›PMID 40416691›Full record

ArticleFrontiers in public health2025

The effect of overuse by primary healthcare institutions on medical expenses: an empirical study from the western regions of China.

Yao Zhang, Yingqi Liu, Zhengxue Luo, Zhongliang Zhou, Shaoqing Gong

Abstract read
In one paragraph

Article in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yao Zhang *Department of Health Career Management and Medical Education, The Ministry of Education Key Lab of Hazard Assessment and Control in Special Operational Environment, Military Preventive Medical College, The Fourth Military Medical University, Xi'an, Shaanxi, China.
Yingqi Liu *China Institute for Hospital Development and Reform, Xi'an Jiaotong University, Xi'an, Shaanxi, China.
Zhengxue LuoHospital Centre Office, Air Force Medical Center, Beijing, China.
Zhongliang ZhouSchool of Public Policy and Administration, Xi'an Jiaotong University, Xi'an, Shaanxi, China.
Shaoqing GongLuohe Medical College, Luohe, Henan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Overuse stands as an important factor in the unreasonable growth of healthcare expenditure in many countries, increasing the burden of both patients and national healthcare insurance. The heterogeneity of diseases results in significant differences in clinical manifestations and treatment sensitivity among different patients with the same illness, making it urgently necessary to explore and resolve the objective assessment and measurement of overuse. This study aims to investigate the current status of overuse in primary healthcare services in China, analyze and discuss the effect of overuse on medical expenses, and draw attention to the issue of overuse. Method: The study adopted unannounced standardized patients to conduct 242 effective visits to 156 primary medical institutions in western Chinese province. The number of unnecessary medical service items reported after the visits is used to determine whether overuse exists. We set up a multiple linear regression model and used statistical methods to analyze the effect of different types of overuse on various medical expenses incurred by patients. Results: (1) Among the 242 visits, overtreatment occurred 139 times, accounting for 57.44% of the total visits. Among them, over-examination accounted for 37.41%, and over-medication accounted for 62.58%. (2) Regarding medical expenditure, the average total medical cost per capita for the 242 valid visits was 32.73 yuan, with examination fees amounting to 22.96 yuan and drug costs totaling 13.60 yuan. (3) Compared to the non-overuse group, patients in the overuse group incurred a total cost of 106.57 yuan, which was 54.33 yuan higher. The examination fees for the overuse group were 69.74 yuan, representing an additional expenditure of 18.83 yuan compared to the non-overuse patients. Drug costs for the overuse group were 39.27 yuan, an increase of 35.74 yuan compared to the non-overuse patients. Thus, overuse led to an increase of 104, 27, and 91% in total medical costs, examination fees, and drug costs, respectively. (4) For every additional unnecessary medical service item, the total medical cost will increase by 18.66 yuan, the examination cost will increase by 3.65 yuan, and the drug cost will increase by 14.48 yuan, with an increase rate of 13, 17, and 20%, respectively. For every additional unnecessary medical examination, the examination cost will increase by 11.28 yuan, with an increase rate of 13%, while there is no significant impact on total medical costs and drug costs. For every additional unnecessary drug item, the total medical cost will increase by 19.71 yuan, and the drug cost will increase by 9.81 yuan, with an increase rate of 29 and 27%, respectively, while there is no significant impact on examination costs. Conclusion: The study found that overuse is highly prevalent in primary healthcare institutions in the western provinces of China, including two types: over-examination and over-medication, with the problem of excessive medication being more prominent. Overuse has led to an increase in medical expenses, which is specifically reflected in the rise of total medical costs and drug costs. The growth in the number of unnecessary medical items is the main cause of the unreasonable rise in medical expenses.

Indexed as

Health ExpendituresMedical OverusePrimary Health CareAdultAgedChinaEmpirical ResearchFemaleHumansMaleMiddle Agedmedical expensesoveruseprimary healthcare servicesunannounced standardized patientwestern regions of China

Identifiers

PMID40416691
PMCPMC12100661

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.